COMP <GO>
BON vs UNH // NET PROFIT MARGIN
Bon Natural Life Limited (Class A) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BON 0
— UNH 9
▲ NET PROFIT MARGIN LEADER: UNH
LAST: $1.13 (-0.01%) • MKT CAP: $9.2M
net-margins
-10.70%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BON VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BON | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.80% | 88.57% | -67.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 11.47% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.46% | 6.48% | -5.02 | UNH | /fcf-yield <GO> |
| Operating Margin | -8.70% | 4.82% | -13.52 | UNH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -10.70% | 3.14% | -13.84 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -21.70% | 6.46% | -28.16 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.0 | 59.2 | -11.21 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.2M | $368.83B | -$368.82B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BON REV | UNH REV | BON GROSS % | UNH GROSS % | BON FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.7M | $447.57B | 20.8% | 88.7% | $134.3K | $16.07B |
| FY 2024 | $23.8M | $400.28B | 29.8% | 88.3% | -$7.7M | $20.70B |
| FY 2023 | $29.5M | $371.62B | — | 89.6% | -$616.9K | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BON // BETA —
UNH // BETA 0.33